Treatment of refractory peripheral T-cell lymphoma with denileukin diftitox (ONTAK)

Leukemia & Lymphoma
Rakhshandra TalpurMadeleine Duvic

Abstract

Peripheral T-cell lymphomas (PTCLs) are an uncommon and heterogeneous group of well-differentiated, post-thymic T-cell malignancies that can present in the skin as cutaneous T-cell lymphomas. In general, their prognosis is poor, and specific therapy is not well defined. We report the successful treatment of a patient with relapsed, refractory PTCL who after failing 13 standard single and multiple chemotherapy regimens and experimental agents had a dramatic prolonged response to diftitoxin denileukin (ONTAK). This fusion protein, composed of diphtheria toxin coupled to interleukin-2, is approved for cutaneous T-cell lymphomas, including mycosis fungoides, and should be considered for treatment of the rare subset of peripheral T-cell lymphomas.

References

Dec 1, 1991·Journal of Korean Medical Science·Y H Ko, J D Lee
Mar 1, 1995·Journal of the American Academy of Dermatology·R T HoppeG S Wood
Mar 5, 1998·Journal of the American Academy of Dermatology·E C VonderheidM A Wasik
Oct 28, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E CampoE Montserrat
Oct 28, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A López-GuillermoE Montserrat
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R KurzrockM Duvic
Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P L ZinzaniS Tura
Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E OlsenJ Nichols

❮ Previous
Next ❯

Citations

Jan 14, 2003·Hematological Oncology
Jun 11, 2010·International Journal of Hematology·Jasmine M Zain, Owen O'Connor
Apr 16, 2009·Current Opinion in Hematology·Bruce D Cheson
Oct 10, 2006·The AAPS Journal·Robert J Kreitman
Dec 15, 2012·Critical Reviews in Oncogenesis·Clifford WhatcottDaniel D Von Hoff
Apr 7, 2009·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Robert J Kreitman
Aug 8, 2008·Future Oncology·Madeleine Duvic, Rakhshandra Talpur
Apr 30, 2003·Expert Opinion on Biological Therapy·Arthur E FrankelRonald Gartenhaus
Jul 23, 2004·Expert Opinion on Biological Therapy·Robert J Kreitman
Jan 9, 2003·Expert Opinion on Biological Therapy·Robert J Kreitman
Jul 26, 2003·Expert Opinion on Biological Therapy·Uwe TrefzerKhusru Asadullah
Sep 21, 2007·Cancer Investigation·Bryan Y WongNam H Dang
Jul 17, 2010·Mayo Clinic Proceedings·Prashant KapoorPhilip R Greipp
May 27, 2008·Clinical Lymphoma & Myeloma·Kelley VidulichMadeleine Duvic
Jan 2, 2007·Cancer Letters·Amit W Panwalkar, James O Armitage
Jan 20, 2007·British Journal of Haematology·Nam H DangLuis Fayad
Jul 16, 2010·British Journal of Haematology·Francesco d'AmoreHans Hagberg
Apr 13, 2011·British Journal of Haematology·Claire E DeardenUNKNOWN British Committee for Standards in Haematology
May 20, 2004·International Journal of Medical Microbiology : IJMM·David J FitzGeraldIra Pastan
May 25, 2004·Leukemia & Lymphoma·Robert Marcus
Apr 24, 2012·Clinical Lymphoma, Myeloma & Leukemia·Rakhshandra Talpur, Madeleine Duvic
Jan 20, 2007·Journal of Cutaneous Medicine and Surgery·Anatoli Freiman, Denis Sasseville
Apr 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven Le GouillUNKNOWN Société Française de Greffe de Moëlle et de Thérapie Cellulaire
Sep 9, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nam H DangLuis Fayad
Apr 4, 2013·Bioorganicheskaia khimiia·S I RomaniukS V Komisarenko
Nov 25, 2006·Hematology·John P Greer
Oct 8, 2005·Blood·Mujahid A RizviSteven T Rosen
Jul 6, 2004·Current Treatment Options in Oncology·Andrew M Evens, Ronald B Gartenhaus
May 16, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yohei YamadaTatsuo Kawai
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dan JonesL Jeffrey Medeiros
Aug 27, 2003·Seminars in Oncology·Arthur E FrankelStephen H Leppla

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Nam H DangLuis Fayad
Biochemical and Biophysical Research Communications
V K ChaudharyI Pastan
© 2022 Meta ULC. All rights reserved